IMBdx

コア技術

がんの早期発見

発表

게시물 목록
番号	年度	題名	雑誌	リンクを見る
18	2025	Clinical Utility of Circulating Tumor DNA for Tumor Profiling and Monitoring in High-Grade Serous Ovarian Cancer Clinical Utility of Circulating Tumor DNA for Tumor Profiling and Monitoring in High-Grade Serous Ovarian Cancer AACR-KCA Profiling Clinical Utility of Circulating Tumor DNA for Tumor Profiling and Monitoring in High-Grade Serous Ovarian Cancer	AACR-KCA
17	2025	Performance of a tissue-agnostic approach based on whole-genome methylation and fragmentomics features for detecting minimal residual disease (MRD) in colorectal cancer (CRC) and its comparison with a clinically validated, tissue-informed Performance of a tissue-agnostic approach based on whole-genome methylation and fragmentomics features for detecting minimal residual disease (MRD) in colorectal cancer (CRC) and its comparison with a clinically validated, tissue-informed MRD assay European Society for Medical Oncology (ESMO) MRD monitoring Performance of a tissue-agnostic approach based on whole-genome methylation and fragmentomics features for detecting minimal residual disease (MRD) in colorectal cancer (CRC) and its comparison with a clinically validated, tissue-informed	European Society for Medical Oncology (ESMO)
16	2025	"Utilizing cfDNA Fragment Traits to Identify CHIP in Canonical and Non-Canonical Genes with Machine Learning" Utilizing cfDNA Fragment Traits to Identify CHIP in Canonical and Non-Canonical Genes with Machine Learning JCA-AACR Profiling "Utilizing cfDNA Fragment Traits to Identify CHIP in Canonical and Non-Canonical Genes with Machine Learning"	JCA-AACR
15	2025	Postoperative Minimal Residual Disease Detection Using Tumor-Informed Circulating Tumor DNA Analysis in Stage II-III Gastric Cancer Postoperative Minimal Residual Disease Detection Using Tumor-Informed Circulating Tumor DNA Analysis in Stage II-III Gastric Cancer American Assoiation for Cancer Research (AACR) MRD monitoring Postoperative Minimal Residual Disease Detection Using Tumor-Informed Circulating Tumor DNA Analysis in Stage II-III Gastric Cancer	American Assoiation for Cancer Research (AACR)
14	2025	Preliminary Results of Perioperative Minimal Residual Disease Monitoring Using a Tumor-informed ctDNA Assay in Stage II-III Breast Cancer Preliminary Results of Perioperative Minimal Residual Disease Monitoring Using a Tumor-informed ctDNA Assay in Stage II-III Breast Cancer American Assoiation for Cancer Research (AACR) MRD monitoring Preliminary Results of Perioperative Minimal Residual Disease Monitoring Using a Tumor-informed ctDNA Assay in Stage II-III Breast Cancer	American Assoiation for Cancer Research (AACR)